These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9487143)

  • 21. Inhibition of growth factor-dependent inositol phosphate Ca2+ signaling by antitumor ether lipid analogues.
    Seewald MJ; Olsen RA; Sehgal I; Melder DC; Modest EJ; Powis G
    Cancer Res; 1990 Aug; 50(15):4458-63. PubMed ID: 2369723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of antineoplastic phospholipids on parameters of cell differentiation in U937 cells.
    Hochhuth C; Berkovic D; Eibl H; Unger C; Doenecke D
    J Cancer Res Clin Oncol; 1990; 116(5):459-66. PubMed ID: 1699946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevation of leukemic cell intracellular calcium by the ether lipid SRI 62-834.
    Lazenby CM; Thompson MG; Hickman JA
    Cancer Res; 1990 Jun; 50(11):3327-30. PubMed ID: 2334926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alkylphospholipids reversibly open epithelial tight junctions.
    Leroy A; de Bruyne GK; Oomen LC; Mareel MM
    Anticancer Res; 2003; 23(1A):27-32. PubMed ID: 12680191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiinvasive activity of hexadecylphosphocholine in vitro.
    Schallier DC; Bruyneel EA; Storme GA; Hilgard P; Mareel MM
    Anticancer Res; 1991; 11(3):1285-92. PubMed ID: 1888162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Edelfosine and miltefosine effects on lipid raft properties: membrane biophysics in cell death by antitumor lipids.
    Castro BM; Fedorov A; Hornillos V; Delgado J; Acuña AU; Mollinedo F; Prieto M
    J Phys Chem B; 2013 Jul; 117(26):7929-40. PubMed ID: 23738749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein kinase C inhibition by ET-18-OCH3 and related analogs. A target for cancer chemotherapy.
    Pauig SB; Daniel LW
    Adv Exp Med Biol; 1996; 416():173-80. PubMed ID: 9131145
    [No Abstract]   [Full Text] [Related]  

  • 28. Alkyl-lysophospholipids as anticancer agents and enhancers of radiation-induced apoptosis.
    Ruiter GA; Verheij M; Zerp SF; van Blitterswijk WJ
    Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):415-9. PubMed ID: 11173135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Caenorhabditis elegans as a platform to study the mechanism of action of synthetic antitumor lipids.
    Sánchez-Blanco A; Rodríguez-Matellán AG; Reis-Sobreiro M; Sáenz-Narciso B; Cabello J; Mohler WA; Mollinedo F
    Cell Cycle; 2014; 13(21):3375-89. PubMed ID: 25485582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ether lipids in the therapy of cancer.
    Andreesen R
    Prog Biochem Pharmacol; 1988; 22():118-31. PubMed ID: 3043427
    [No Abstract]   [Full Text] [Related]  

  • 31. Antitumor activity of the R- and S-enantiomers of RS-2-[[hydroxy[[2-[ (octadecyloxy)methyl]tetrahydrofuran-2-yl]methoxy]-phosphinyl]oxy]-N, N,N,-trimethylethylaminium hydroxide inner salt.
    Houlihan WJ; Prasad K; Underwood R; Repic O; Munder PG
    J Med Chem; 1996 Jan; 39(2):605-8. PubMed ID: 8558533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycosylated antitumor ether lipids: activity and mechanism of action.
    Arthur G; Bittman R
    Anticancer Agents Med Chem; 2014 May; 14(4):592-606. PubMed ID: 24628233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes of intracellular calcium, fatty acids and phospholipids during miltefosine-induced apoptosis monitored by fluorescence- and 13C NMR-spectroscopy.
    Henke J; Engelmann J; Kutscher B; Nssner G; Engel J; Voegeli R; Leibfritz D
    Anticancer Res; 1999; 19(5B):4027-32. PubMed ID: 10628349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipid rafts and metabolic energy differentially determine uptake of anti-cancer alkylphospholipids in lymphoma versus carcinoma cells.
    Vink SR; van der Luit AH; Klarenbeek JB; Verheij M; van Blitterswijk WJ
    Biochem Pharmacol; 2007 Nov; 74(10):1456-65. PubMed ID: 17803969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Platelet-activating factor (PAF) antagonists].
    Terasawa M
    Tanpakushitsu Kakusan Koso; 1991 Feb; 36(3):379-87. PubMed ID: 1850862
    [No Abstract]   [Full Text] [Related]  

  • 36. Design and synthesis of new adamantyl-substituted antileishmanial ether phospholipids.
    Papanastasiou I; Prousis KC; Georgikopoulou K; Pavlidis T; Scoulica E; Kolocouris N; Calogeropoulou T
    Bioorg Med Chem Lett; 2010 Sep; 20(18):5484-7. PubMed ID: 20719503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phospholipid antitumor agents.
    Houlihan WJ; Lohmeyer M; Workman P; Cheon SH
    Med Res Rev; 1995 May; 15(3):157-223. PubMed ID: 7658750
    [No Abstract]   [Full Text] [Related]  

  • 38. Role of endocytosis in the action of ether lipids on WEHI-3B, HL60, and FDCP-mix A4 cells.
    Bazill GW; Dexter TM
    Cancer Res; 1990 Dec; 50(23):7505-12. PubMed ID: 2253199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipid rafts as major platforms for signaling regulation in cancer.
    Mollinedo F; Gajate C
    Adv Biol Regul; 2015 Jan; 57():130-46. PubMed ID: 25465296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The alkylphospholipid edelfosine shows activity against Strongyloides venezuelensis and induces apoptosis-like cell death.
    Legarda-Ceballos AL; Rojas-Caraballo J; López-Abán J; Ruano AL; Yepes E; Gajate C; Mollinedo F; Muro A
    Acta Trop; 2016 Oct; 162():180-187. PubMed ID: 27394030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.